Designing the valve and the flow field around it.
Chronic venous insufficiency affects millions of people worldwide, and its most advanced stages leave the fewest options. For CEAP C5 and C6 disease — where venous ulcers recur or fail to heal — durable, restorative solutions remain limited. Piezolabs innovation is being developed to address that gap.
Piezolabs Medical is developing an implantable venous valve platform for patients with severe chronic venous disease, with a design philosophy focused on durable valve function, physiologic hemodynamics, and lessons learned from prior device failures.
Investigational device. It is not available for sale and has not been cleared or approved by the U.S. Food and Drug
